Marina Biotech Receives Notice of Allowance for U.S. Patent Related to Its Nucleic Acid-Peptide Drug Delivery Platform

by Matthew Kennedy, Benzinga Staff Writer
September 1, 2011 8:33 AM | 12 seconds read |
Marina Biotech, Inc. MRNA, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application U.S. 11/955,207 with claims that cover a library of over 1x10(15) novel peptides.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsFDAHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!